Sippican Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$731K |
| 2 |
Columbia Banking Systems
COLB
|
+$685K |
| 3 |
Pfizer
PFE
|
+$564K |
| 4 |
Alerus Financial
ALRS
|
+$550K |
| 5 |
Eli Lilly
LLY
|
+$491K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Organon & Co
OGN
|
+$1.72M |
| 2 |
DOC
PHYSICIANS REALTY TRUST
DOC
|
+$1.19M |
| 3 |
CATC
CAMBRIDGE BANCORP
CATC
|
+$1M |
| 4 |
3M
MMM
|
+$877K |
| 5 |
Viatris
VTRS
|
+$632K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.62% |
| 2 | Healthcare | 16.35% |
| 3 | Energy | 14.17% |
| 4 | Consumer Discretionary | 10.71% |
| 5 | Industrials | 9.61% |
Similar funds
Sippican Capital Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, Sippican Capital Advisors held 124 positions worth $127M, up 15% from $111M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Sippican Capital Advisors deployed $5.14M of net new capital in Q4 2023, opening 15 new positions and adding to 48 existing holdings. Its largest new stake was Columbia Banking Systems: 30,800 shares worth $822K.
By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 26% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was PHYSICIANS REALTY TRUST, an estimated $1.19M trimmed.
- Sippican Capital Advisors's largest Q4 2023 buy was Columbia Banking Systems: 30,800 shares worth $822K.
- Sippican Capital Advisors added most to JPMorgan Chase in Q4 2023, an estimated $731K increase.
- Sippican Capital Advisors's biggest Q4 2023 reduction was PHYSICIANS REALTY TRUST, cutting an estimated $1.19M.
- Sippican Capital Advisors fully exited Organon & Co in Q4 2023, selling an estimated $1.72M.
- Sippican Capital Advisors's ten largest holdings make up 25% of its $127M portfolio in Q4 2023.
- Sippican Capital Advisors opened 15 new positions and closed 7 in Q4 2023.
- Sippican Capital Advisors's portfolio value rose 15% quarter-over-quarter to $127M.
Based on Sippican Capital Advisors's 13F filing for Q4 2023, filed 30 Jan 2024.